Concerns growing over cash reward system

Concerns are growing in local pharmaceutical industry over the government’s cash reward system whose implementation has been delayed until end-December this year.

Under the system, when a hospital buys a drug for less than a set price, the National Health Insurance Corporation pays back 70 percent of the difference. So if a drug’s reimbursement ceiling is 1,000 won, then a hospital that buys...